explore -WSS

explore

author：explore 2025-09-30 08:52:14 - browse：227

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Novo: Oral version of Ozempic leads to 15% weight loss

hotspot

WSS

Bristol 'take

Sea level rise could wash away turtle breeding grounds around the world, researchers say

A Q&A with the global head of Boehringer Ingelheim's innovation unit

AI can decode, harness the power of the humane immune system

Biden administration plans revamp of organ transplant system

Phenylephrine and the overlooked value of the placebo effect

focus

explore

hotspot

In Memoriam: Notable people who died in 2023

Why age limits for politicians are a terrible idea

Tori Bowie and the unacceptable rates of Black maternal death

Colorectal cancer study finds potential in overlooked immune cell

The high cost of giving birth even with insurance

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Activists slam private health insurers over coverage restrictions

Colorectal cancer study finds potential in overlooked immune cell

New air purifier tech could be key to improving indoor air quality

FDA panel signals lack of confidence in Amgen cancer drug data

entertainment

FDA panel signals lack of confidence in Amgen cancer drug data

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Sana to lay off nearly a third of staff, de

Reanimated hearts work just as well for transplants, study finds

Why age limits for politicians are a terrible idea

How to fix the rural physician shortage in the U.S.

entertainment

hotspot

hotspot

leisure time